Please verify your email address to receive email notifications.

Enter your email address

We have sent you a verification email. Please check your inbox and spam folder.

Unable to send verification, please refresh and try again later.

  • Q&A with Australian Health Practitioners

    How does one obtain inflixamab for the treatment of Ulcerative colitis?

    Related Topic
    Crohn's Disease & Ulcerative Colitis
    I have heard that infliximab has now been approved in Australia for Ulcerative Colitis as from 1 December. Does any one know how you can get this treatment? What is the criteria to be able to get this treatment? thank you
    answer this question

  • Find a professional to answer your question

  • 1

    Thanks

    Crohn's & Colitis Australia

    For more than 25 years, Crohn’s & Colitis Australia™ (formerly the Australian Crohn’s and Colitis Association) has been making life more liveable for more than … View Profile

    Patients with moderate to severe ulcerative colitis may be eligible for treatment with infliximab based on the following criteria:

    - have failed to respond to a 5ASA medication (e.g. mesalazine) for three or more months

    - have failed to respond to an immunomodulator (such as azathioprine or mercaptopurine), or

    - have had a disease activity test (e.g. Mayo or PUCAI) done confirming the severity of their disease.

    The above criteria does not apply to patients who have previously received infliximab. Individual advice should be sought by consulting your gastroenterologist.

    Reply to this post
     · 
    Report
    Reply to this post

    You must be a Health Professional to reply to this post. to your account or now (it's free).

answer this question

You must be a Health Professional to answer this question. Log in or Sign up .

You may also like these related questions

Related Questions

Empowering Australians to make better health choices